Press releases | WebDisclosure

Basculer en Français

10966	Companies
240147	Keywords
168916	Articles
129242	Press releases

Home
Press releases

PRESS RELEASE

published on 02/02/2026 at 07:30, 7 months 11 days ago

Carvolix is born and funded
French medtech company Affluent Medical rebrands as Carvolix after acquiring Caranx Medical and Artedrone. Completes 10m€ financing with Truffle Capital and Edwards Lifesciences for breakthrough AI-driven mini-robots and biomimetic implants in interventional cardiology and brain stroke treatment. Focus on expanding market and long-term value creation

Affluent Medical Carvolix AI-driven Mini-robots Medtech Company Biomimetic Implants
PRESS RELEASE

published on 02/02/2026 at 07:30, 7 months 11 days ago

Carvolix : Résultats du vote de l’Assemblée Générale Mixte du 30 janvier 2026
Résultats du vote de l’Assemblée Générale Mixte de Carvolix du 30 janvier 2026. Approbation des résolutions et nominations. Détails des votes et taux de participation

Résultats Assemblée Générale Mixte Vote Financières Carvolix
PRESS RELEASE

published on 02/02/2026 at 07:30, 7 months 11 days ago

Carvolix : Results of the votes of the Combined Shareholders’ General Meeting of January 30, 2026
Carvolix (formerly Affluent Medical) announces results of Combined Shareholders' Meeting, including name change approval and board member appointment

Medical Technology Affluent Medical AI-driven Technology Combined Shareholders' Meeting Carvolix
PRESS RELEASE

published on 02/02/2026 at 07:30, 7 months 11 days ago

Carvolix est né et financé
Affluent Medical devient officiellement CARVOLIX suite à l'acquisition de Caranx Medical et Artedrone pour révolutionner la cardiologie interventionnelle et les traitements des AVC avec des mini-robots IA et implants biomimétiques

Acquisition Affluent Medical MedTech Carvolix Mini-robots IA
PRESS RELEASE

published on 02/02/2026 at 07:30, 7 months 11 days ago

Verve Group SE Announces Intention to Issue Subsequent Bonds to Capitalize on Business Momentum Following Strong Q4 Performance
Verve Group SE intends to issue subsequent bonds following strong Q4 performance to capitalize on business momentum. The Company plans an aggregate total of €50 million

Fixed Income Business Momentum Q4 Performance Subsequent Bonds Verve Group SE
PRESS RELEASE

published on 02/02/2026 at 07:30, 7 months 11 days ago

Affluent Medical officially becomes CARVOLIX
Affluent Medical officially becomes CARVOLIX after completing the acquisitions of CARANX MEDICAL and ARTEDRONE, with a 10m€ first tranche of financing. Carvolix focuses on revolutionizing cardiac valve replacement and brain stroke treatment

Innovation Acquisitions Financing Medical Technology Carvolix
PRESS RELEASE

published on 02/02/2026 at 07:05, 7 months 11 days ago

Julius Baer Group announces changes to the Board of Directors
Julius Baer Group announces changes to the Board of Directors, including Richard Campbell-Breeden stepping down as Vice Chairman and Juerg Hunziker succeeding him. Urban Angehrn to join the Board as independent non-executive Director

Board Of Directors Julius Baer Urban Angehrn Richard Campbell-Breeden Juerg Hunziker
PRESS RELEASE

published on 02/02/2026 at 07:01, 7 months 11 days ago

EQS-Adhoc: Update of a release from 24/08/2025, 19:30 CET/CEST - Intended changes in the group structure at the level of the majority shareholder Highlight Event and Entertainment AG
Update on changes in group structure of Highlight Event and Entertainment AG, including planned capital increase with new investor CSL Mindset Ltd

Capital Increase Equity Investment Group Structure Highlight Event And Entertainment AG CSL Mindset Ltd.
PRESS RELEASE

published on 02/02/2026 at 07:00, 7 months 11 days ago

Presentation of the 2025 full-year results for the Julius Baer Group
Julius Baer Group presents its 2025 full-year results, with 5% growth in AuM to CHF 521 billion and a proposed ordinary dividend of CHF 2.60 per share for 2025

Financial Results Dividend Assets Under Management 2025 Julius Baer Group
PRESS RELEASE

published on 02/02/2026 at 07:00, 7 months 11 days ago

Highlight Event and Entertainment AG: Update on CSL Mindset Ltd. transaction
Highlight Event and Entertainment AG provides an update on the CSL Mindset Ltd. transaction, with delays in implementation and open timing for the transaction

Transaction Delay Highlight Event Entertainment AG CSL Mindset Ltd.

Accesswire

Published on 09/12/2026 at 02:35, 1 day 12 hours ago

Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 1 day 16 hours ago

Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 22:05, 1 day 17 hours ago

Usha Resources Announces Leadership Transition
Published on 09/11/2026 at 21:25, 1 day 17 hours ago

Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 1 day 22 hours ago

Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors

View all ACCESSWIRE

EQS Group

Published on 09/12/2026 at 17:50, 21 hours 30 minutes ago

New Delhi Marks UN Day for South-South Cooperation with Push to Scale Dryland Innovation Across the Global South
Published on 09/12/2026 at 07:30, 1 day 7 hours ago

NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 1 day 17 hours ago

Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 1 day 17 hours ago

Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 1 day 19 hours ago

DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031

Les Echos

Published on 09/11/2026 at 07:00, 2 days 8 hours ago

Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 2 days 8 hours ago

Transparency notification by Baltisse Group
Published on 09/11/2026 at 07:00, 2 days 8 hours ago

BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 2 days 8 hours ago

BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 2 days 19 hours ago

Availability of the 2026 Interim Financial Report

View all LES ECHOS COMFI WIRE